Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Wild leek (Allium tricoccum) contains sulfur compounds, primarily alliin, that convert to allicin upon tissue damage, inhibiting the NF-κB inflammatory pathway and upregulating IκB-α protein expression to reduce iNOS and COX-2 activity. Research demonstrates that dietary supplementation of A. tricoccum leaves improves lipid profiles, intestinal morphology, and nutrient digestibility in animal models (PMID 39066801), while the broader Allium genus provides robust evidence for cardiovascular, antioxidant, and antimicrobial benefits (PMID 32088245).
Reported Benefits (Provisional)
Origin & History
Wild Leek (*Allium tricoccum*) is a perennial herbaceous plant native to the temperate forests of Eastern North America. It thrives in rich, moist soils and is traditionally foraged in early spring. Prized for its distinctive pungent flavor and dense nutritional profile, Wild Leek is a valuable functional food.
Research Narrative (Provisional)
Abdulkareem et al. (2024) demonstrated that dietary supplementation with wild leek (Allium tricoccum) leaves in laying quails significantly improved serum lipid profiles, intestinal villus morphology, and nutrient digestibility compared to controls (Trop Anim Health Prod; PMID 39066801). Kılınç et al. (2023) reported that supplemental dried wild leek (Allium scorodoprasum L. subsp. rotundum) leaves enhanced laying performance, egg quality, and oxidative stability in laying hens, indicating measurable antioxidant capacity in vivo (Trop Anim Health Prod; PMID 37087514). Ekşi et al. (2020) provided a comprehensive ethnopharmacological review of Allium species including wild leek, confirming traditional and pharmacological evidence for cardiovascular protection, antimicrobial action, and anti-inflammatory effects attributed to organosulfur compounds and flavonoids (J Ethnopharmacol; PMID 32088245). Trichopoulou (2001) contextualized wild Allium vegetables within Mediterranean dietary patterns associated with reduced cardiovascular mortality and cancer incidence (Int J Vitam Nutr Res; PMID 11582835).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Sulfur compounds (Allicin), Flavonoids (Kaempferol). - Vitamins: Vitamin A, Vitamin C, Folate. - Minerals: Iron, Manganese, Potassium. - Macronutrients: Dietary Fiber.
Reported Mechanism (Provisional)
Wild leek's principal bioactive compound alliin is enzymatically converted to allicin by the alliinase enzyme upon tissue disruption, generating thiosulfinates and ajoene derivatives that target multiple inflammatory and oxidative pathways. Allicin and its metabolites inhibit the NF-κB transcription factor by stabilizing and upregulating IκB-α (inhibitor of nuclear factor kappa B, alpha) protein, thereby suppressing downstream expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), key mediators of inflammation and prostaglandin synthesis. The flavonoid fraction, rich in quercetin and kaempferol, provides complementary antioxidant activity by scavenging reactive oxygen species (ROS), chelating transition metals, and modulating the Nrf2/ARE signaling axis to upregulate endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). Additionally, organosulfur compounds disrupt bacterial biofilm formation and viral replication by interfering with thiol-dependent enzyme systems, contributing to the plant's broad-spectrum antimicrobial properties.
Clinical Narrative (Provisional)
Evidence for wild leek primarily comes from in vitro laboratory studies rather than human clinical trials. Studies using RAW264.7 immune cells demonstrated complete nitric oxide production inhibition at 1.0 mg/mL concentration and reduced inflammatory protein expression at 0.5 mg/mL. Antioxidant activity showed dose-dependent increases in the 0.01-1.0 mg/mL range using TEAC methodology. Human clinical trial data with specific patient outcomes and therapeutic dosages remains limited.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.